Home
|Insights
|The Long and Winding Road for BIOSIMILARS: Charting a Pathway through Patent, FDA, Antitrust, Prescription Filling, Reimbursement and Liability Law

PDF Link

The Long and Winding Road for BIOSIMILARS: Charting a Pathway through Patent, FDA, Antitrust, Prescription Filling, Reimbursement and Liability Law

Publication | 09.18.15

Contacts

Barbara H. Ryland
Senior Counsel
- Washington, D.C.
  - D | +1.202.624.2970
YnJ5bGFuZEBjcm93ZWxsLmNvbQ==

Insights

Publication | 10.17.26

UK defence procurement: Managing legal risk as investment grows

Publication | 10.16.26
New Developments in California’s Corporate Practice of Medicine Law Raises Compliance and Litigation Considerations for Payers and Providers Alike
Publication | 10.15.26
New York State Department of Financial Services Ramps Up Health Care Cybersecurity Enforcement With $2.25 Million Settlement
Publication | 10.12.26
The Liquidity Imperative: Opportunity and Risk in Next-Generation Collateral Enhancement

View All Insights

Subscribe

to the latest insights from our team